Old Web
English
Sign In
Acemap
>
authorDetail
>
Fabienne Emery-Salbert
Fabienne Emery-Salbert
Novartis
Midostaurin
Immunology
Medicine
Neutropenia
Chronic myelomonocytic leukemia
3
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial
2014
Blood
Jason Gotlib
Hanneke C. Kluin-Nelemans
Tracy I. George
Cem Akin
Karl Sotlar
Olivier Hermine
Farrukh T. Awan
Elizabeth O. Hexner
Michael J. Mauro
David Sternberg
Matthieu Villeneuve
Fabienne Emery-Salbert
Eric J. Stanek
Karin Hartmann
Hans-Peter Horny
Peter Valent
Andreas Reiter
Show All
Source
Cite
Save
Citations (19)
Durable Responses and Improved Quality Of Life With Midostaurin (PKC412) In Advanced Systemic Mastocytosis (SM): Updated Stage 1 Results Of The Global D2201 Trial
2013
Blood
Hanneke C. Kluin-Nelemans
Tracy I. George
Cem Akin
Karl Sotlar
Olivier Hermine
Farrukh T. Awan
Elizabeth O. Hexner
Michael J. Mauro
Rodica Morariu
Margaret Squier
Matthieu Villeneuve
Fabienne Emery-Salbert
John Coombs
Karin Hartmann
Hans-Peter Horny
Peter Valent
Andreas Reiter
Show All
Source
Cite
Save
Citations (10)
KIT Inhibitor Midostaurin in Patients with Advanced Systemic Mastocytosis: Results of a Planned Interim Analysis of the Global CPKC412D2201 Trial
2012
Blood
Jason Gotlib
Hanneke C. Kluin-Nelemans
Tracy I. George
Cem Akin
Karl Sotlar
Olivier Hermine
Farrukh T. Awan
Elizabeth O. Hexner
Michael J. Mauro
Rodica Morariu
Margaret Squier
Matthieu Villeneuve
Fabienne Emery-Salbert
Karin Hartmann
Hans-Peter Horny
Peter Valent
Andreas Reiter
Show All
Source
Cite
Save
Citations (21)
1